Journal article
Implications of using a prognostic index to select therapy for patients with aggressive histology lymphoma.
Abstract
The International Non-Hodgkin's Lymphoma Prognostic Factor Index (INHLPF-Index) is a validated method of determining prognosis for patients with aggressive histology lymphoma and is now being used to identify those who might benefit most from new investigative therapies. This review assesses its usefulness and potential clinical utility in this context, and shows that several factors will determine the clinical utility of using this index, …
Authors
Meyer RM; Browman GP
Journal
The Canadian Journal of Oncology, Vol. 5, No. 1, pp. 344–354
Publication Date
3 1995
ISSN
1183-2509